Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
GSK revenue increased from £30.8 billion in 2018 to £33.8 billion in 2019, a (9.5%) increase.

Annual Revenue (£)

GSK revenue was £33.75 b in FY, 2019 which is a (9.5%) year over year increase from the previous period.

Quarterly Revenue (£)

FY, 2016FY, 2017FY, 2018FY, 2019
Revenue£27.89 b£30.19 b£30.82 b£33.75 b
Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020
Revenue£7.38 b£7.32 b£7.84 b£7.22 b£7.31 b£8.09 b£7.66 b£7.81 b£9.39 b£9.09 b£7.62 b£8.65 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

GSK revenue breakdown by business segment: 26.7% from Consumer Healthcare, 21.2% from Vaccines and 52.1% from Global Pharmaceuticals

GSK revenue breakdown by geographic segment: 23.9% from Europe, 34.9% from International and 41.2% from US

FY, 2019FY, 2018FY, 2017FY, 2016
Consumer Healthcare£9 b£7.66 b£7.75 b£7.19 b
Vaccines£7.16 b£5.89 b£5.16 b£4.59 b
Global Pharmaceuticals£17.55 b£17.27 b£17.28 b£16.1 b
FY, 2019FY, 2018FY, 2017FY, 2016
Europe8.07 b7.97 b7.94 b7.5 b
International£11.8 b£10.87 b£10.98 b£10.19 b
US£13.89 b£11.98 b£11.26 b£10.2 b

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu